MUC1 and neoplasm: Furthermore, enhanced antibody-dependent tumor cell cytotoxicity by neutrophils was achieved by targeting the Siglec–sialylated MUC1 immune axis, either by blocking Siglec-9 or by reducing tumor cell sialylation [99].